Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Report: BASi
February 14, 2013
Revenues down 23% in the quarter   Read More »
Financial Report: Hospira
February 13, 2013
Specialty Injectable sales up 12% in the quarter   Read More »
Financial Report: AMRI
February 12, 2013
Unaudited revenues up 44% in the quarter   Read More »
Financial Report: Sanofi
February 7, 2013
Revenues up 3% in the quarter, earnings hurt by generics   Read More »
Financial Report: Teva
February 7, 2013
Revenues down 8% in the quarter   Read More »
Financial Report: Sigma-Aldrich
February 7, 2013
Revenues up 7% in the quarter   Read More »
Financial Report: GlaxoSmithKline
February 6, 2013
Revenues decline 3% in the quarter, new change program accelerates   Read More »
Aesica Names Ops Director
February 5, 2013
Palmer to manage formulated products unit   Read More »
Financial Report: Gilead
February 5, 2013
Revenues up 18% in the quarter   Read More »
Financial Report: Merck
February 1, 2013
Revenues down 5% in the quarter   Read More »
Financial Report: AstraZeneca
January 31, 2013
Loss of exclusivity on multiple brands pummels results   Read More »
Financial Report: Alkermes
January 31, 2013
Revenues up 8% in the quarter   Read More »
Financial Report: Thermo Fisher Scientific
January 31, 2013
Revenues up 6% in the quarter   Read More »
Financial Report: PAREXEL
January 30, 2013
Revenues up 25% in the quarter   Read More »
Financial Report: Roche
January 30, 2013
Pharma sales up 2% in the quarter   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: